microRNA information: hsa-miR-708-3p

SectionIDlink
Mature name: hsa-miR-708-3pmiRbase
Accession: MIMAT0004927miRbase
Precursor name: hsa-mir-708 miRbase
Precursor accession: MI0005543miRbase
Symbol: MIR708HGNC
RefSeq ID: NR_030598GenBank
Sequence: CAACUAGACUGUGAGCUUCUAG



Reported expression in cancers: hsa-miR-708-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-708-3p

colorectal cancerupregulation"miR-708 and miR-31 were found to be highly express ......"25202407
hsa-miR-708-3p

liver cancerdownregulation"MicroRNA 708 is downregulated in hepatocellular ca ......"26211597Reverse transcription PCR; qPCR
hsa-miR-708-3p

lung cancerupregulation"Increased miR 708 expression in NSCLC and its asso ......"22573352
hsa-miR-708-3p

lymphomaderegulation"We identified an miRNA signature of 7 miRNAs 5 upr ......"23801630
hsa-miR-708-3p

prostate cancerdownregulation"By microarray approach we identified seven miRNAs ......"26831660Microarray; qPCR



Reported cancer pathway affected by hsa-miR-708-3p

miRNAcancerpathwayreportingPUBMEDfunctional study
hsa-miR-708-3p

bladder cancerApoptosis pathway"Bladder cancer cell lines were exposed to normoxic ......"26196183Flow cytometry
hsa-miR-708-3p

colorectal cancerApoptosis pathway"Regulatory roles of microRNA 708 and microRNA 31 i ......"25202407
hsa-miR-708-3p

glioblastomaApoptosis pathway"miR 708 acts as a tumor suppressor in human gliobl ......"23754151
hsa-miR-708-3p

prostate cancerApoptosis pathway"Metformin induces ER stress dependent apoptosis th ......"26075749



Reported cancer prognosis affected by hsa-miR-708-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-708-3p

liver cancerprogression; tumorigenesis; staging; metastasis"MicroRNA 708 is downregulated in hepatocellular ca ......"26211597
hsa-miR-708-3p

lung cancerpoor survival; staging"Increased miR 708 expression in NSCLC and its asso ......"22573352
hsa-miR-708-3p

lung squamous cell cancerstaging"This study contained three phases: 1 marker discov ......"20526284
hsa-miR-708-3p

ovarian cancermetastasis; cell migration; poor survival"Glucocorticoids mediate induction of microRNA 708 ......"25569036
hsa-miR-708-3p

prostate cancerworse prognosis; progression; poor survival; recurrence"In this study we report that miR-708 is a key nega ......"22552290



Reported gene related to hsa-miR-708-3p

miRNAcancergenereportingPUBMED
hsa-miR-708-3p

prostate cancerAKT2"Together our findings suggest that reduced miR-708 ......"22552290
hsa-miR-708-3p

prostate cancerCD44"Together our findings suggest that reduced miR-708 ......"22552290
hsa-miR-708-3p

colorectal cancerCDKN2B"In addition the CDKN2B protein levels were signifi ......"25202407
hsa-miR-708-3p

breast cancerKDM1A"miR-708 could directly target the LSD1 3'UTR to do ......"26833707
hsa-miR-708-3p

ovarian cancerRAP1B"Glucocorticoids mediate induction of microRNA 708 ......"25569036
hsa-miR-708-3p

lung cancerTMEM88"The transcript for TMEM88 gene has a miR-708 bindi ......"22573352



Expression profile in cancer corhorts:




Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-708-3p
MPL
10 cancers: BLCA; BRCA; CESC; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.086; TCGA BRCA -0.111; TCGA CESC -0.079; TCGA ESCA -0.122; TCGA HNSC -0.171; TCGA KIRC -0.081; TCGA LUAD -0.127; TCGA LUSC -0.149; TCGA PAAD -0.185; TCGA PRAD -0.17
hsa-miR-708-3p
HLF
10 cancers: BLCA; BRCA; HNSC; KIRC; LGG; LUAD; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BLCA -0.366; TCGA BRCA -0.169; TCGA HNSC -0.346; TCGA KIRC -0.172; TCGA LGG -0.14; TCGA LUAD -0.374; TCGA PRAD -0.325; TCGA THCA -0.164; TCGA STAD -0.303; TCGA UCEC -0.281
hsa-miR-708-3p
REEP1
9 cancers: BLCA; LGG; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
MirTarget
TCGA BLCA -0.295; TCGA LGG -0.305; TCGA LUAD -0.289; TCGA LUSC -0.187; TCGA PAAD -0.247; TCGA PRAD -0.276; TCGA SARC -0.226; TCGA THCA -0.117; TCGA STAD -0.332
hsa-miR-708-3p
CPEB3
11 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LGG; LUAD; LUSC; PAAD; PRAD; UCEC
MirTarget; miRNATAP
TCGA BLCA -0.141; TCGA BRCA -0.183; TCGA ESCA -0.073; TCGA HNSC -0.287; TCGA KIRC -0.152; TCGA LGG -0.106; TCGA LUAD -0.132; TCGA LUSC -0.185; TCGA PAAD -0.125; TCGA PRAD -0.163; TCGA UCEC -0.099
hsa-miR-708-3p
CAPZA2
10 cancers: BLCA; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; PRAD; SARC; UCEC
MirTarget
TCGA BLCA -0.086; TCGA COAD -0.115; TCGA ESCA -0.084; TCGA HNSC -0.079; TCGA KIRP -0.105; TCGA LUAD -0.082; TCGA LUSC -0.111; TCGA PRAD -0.106; TCGA SARC -0.072; TCGA UCEC -0.081
hsa-miR-708-3p
PPP1R15B
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LGG; LUSC; PRAD; STAD
MirTarget
TCGA BLCA -0.06; TCGA CESC -0.06; TCGA COAD -0.119; TCGA ESCA -0.078; TCGA HNSC -0.063; TCGA KIRC -0.057; TCGA LGG -0.073; TCGA LUSC -0.089; TCGA PRAD -0.061; TCGA STAD -0.056
hsa-miR-708-3p
SLC25A46
9 cancers: BLCA; CESC; COAD; HNSC; LUAD; LUSC; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.05; TCGA CESC -0.068; TCGA COAD -0.092; TCGA HNSC -0.145; TCGA LUAD -0.071; TCGA LUSC -0.066; TCGA PRAD -0.129; TCGA SARC -0.055; TCGA STAD -0.069
hsa-miR-708-3p
CCNDBP1
9 cancers: BLCA; BRCA; COAD; HNSC; LUAD; LUSC; PRAD; SARC; STAD
MirTarget
TCGA BLCA -0.052; TCGA BRCA -0.093; TCGA COAD -0.078; TCGA HNSC -0.09; TCGA LUAD -0.108; TCGA LUSC -0.085; TCGA PRAD -0.053; TCGA SARC -0.078; TCGA STAD -0.088
hsa-miR-708-3p
ATE1
9 cancers: BLCA; COAD; ESCA; HNSC; KIRC; LGG; LUAD; PRAD; SARC
MirTarget
TCGA BLCA -0.112; TCGA COAD -0.106; TCGA ESCA -0.116; TCGA HNSC -0.217; TCGA KIRC -0.086; TCGA LGG -0.107; TCGA LUAD -0.081; TCGA PRAD -0.264; TCGA SARC -0.077
hsa-miR-708-3p
OPHN1
12 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.062; TCGA BRCA -0.09; TCGA HNSC -0.099; TCGA KIRC -0.213; TCGA KIRP -0.098; TCGA LGG -0.137; TCGA LUAD -0.094; TCGA LUSC -0.064; TCGA PRAD -0.157; TCGA SARC -0.069; TCGA STAD -0.074; TCGA UCEC -0.084
hsa-miR-708-3p
NFAT5
9 cancers: BLCA; BRCA; CESC; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD
mirMAP
TCGA BLCA -0.08; TCGA BRCA -0.058; TCGA CESC -0.067; TCGA HNSC -0.094; TCGA KIRC -0.123; TCGA KIRP -0.185; TCGA LUAD -0.097; TCGA LUSC -0.087; TCGA PRAD -0.146
hsa-miR-708-3p
CPEB4
12 cancers: BLCA; BRCA; CESC; HNSC; KIRC; LGG; LUAD; LUSC; PRAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.148; TCGA BRCA -0.091; TCGA CESC -0.09; TCGA HNSC -0.32; TCGA KIRC -0.092; TCGA LGG -0.104; TCGA LUAD -0.142; TCGA LUSC -0.244; TCGA PRAD -0.147; TCGA SARC -0.075; TCGA STAD -0.117; TCGA UCEC -0.107
hsa-miR-708-3p
PRKAR2A
9 cancers: BLCA; CESC; ESCA; HNSC; LUAD; LUSC; PRAD; SARC; STAD
mirMAP
TCGA BLCA -0.099; TCGA CESC -0.153; TCGA ESCA -0.153; TCGA HNSC -0.318; TCGA LUAD -0.13; TCGA LUSC -0.062; TCGA PRAD -0.254; TCGA SARC -0.153; TCGA STAD -0.077
hsa-miR-708-3p
TMX4
10 cancers: BLCA; CESC; ESCA; HNSC; KIRC; LUSC; PAAD; PRAD; SARC; STAD
mirMAP
TCGA BLCA -0.098; TCGA CESC -0.11; TCGA ESCA -0.133; TCGA HNSC -0.18; TCGA KIRC -0.081; TCGA LUSC -0.177; TCGA PAAD -0.144; TCGA PRAD -0.164; TCGA SARC -0.105; TCGA STAD -0.071
hsa-miR-708-3p
RNF38
9 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; SARC
mirMAP
TCGA BLCA -0.111; TCGA BRCA -0.096; TCGA HNSC -0.092; TCGA KIRC -0.078; TCGA KIRP -0.065; TCGA LUAD -0.076; TCGA LUSC -0.054; TCGA PRAD -0.127; TCGA SARC -0.094
hsa-miR-708-3p
DUSP19
10 cancers: BLCA; BRCA; KIRC; KIRP; LGG; LUAD; PRAD; SARC; THCA; STAD
mirMAP
TCGA BLCA -0.148; TCGA BRCA -0.059; TCGA KIRC -0.054; TCGA KIRP -0.057; TCGA LGG -0.125; TCGA LUAD -0.12; TCGA PRAD -0.301; TCGA SARC -0.099; TCGA THCA -0.116; TCGA STAD -0.085
hsa-miR-708-3p
LRRC2
10 cancers: BLCA; BRCA; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD; PRAD; STAD
mirMAP
TCGA BLCA -0.284; TCGA BRCA -0.205; TCGA ESCA -0.523; TCGA HNSC -0.701; TCGA KIRC -0.223; TCGA LUAD -0.263; TCGA LUSC -0.573; TCGA PAAD -0.245; TCGA PRAD -0.245; TCGA STAD -0.23
hsa-miR-708-3p
RAPH1
9 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; UCEC
mirMAP
TCGA BLCA -0.081; TCGA CESC -0.07; TCGA COAD -0.073; TCGA ESCA -0.061; TCGA HNSC -0.132; TCGA KIRC -0.072; TCGA LUAD -0.076; TCGA LUSC -0.149; TCGA UCEC -0.229
hsa-miR-708-3p
KLHL15
10 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LGG; LUAD; PAAD; PRAD; STAD
mirMAP
TCGA BLCA -0.088; TCGA BRCA -0.114; TCGA COAD -0.093; TCGA ESCA -0.077; TCGA KIRC -0.083; TCGA LGG -0.064; TCGA LUAD -0.078; TCGA PAAD -0.113; TCGA PRAD -0.182; TCGA STAD -0.072
hsa-miR-708-3p
EPM2AIP1
10 cancers: BLCA; BRCA; HNSC; KIRC; KIRP; LGG; LUAD; PAAD; PRAD; THCA
mirMAP
TCGA BLCA -0.071; TCGA BRCA -0.067; TCGA HNSC -0.077; TCGA KIRC -0.1; TCGA KIRP -0.121; TCGA LGG -0.069; TCGA LUAD -0.059; TCGA PAAD -0.082; TCGA PRAD -0.079; TCGA THCA -0.074
hsa-miR-708-3p
ZC3H6
9 cancers: BLCA; BRCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD
mirMAP
TCGA BLCA -0.08; TCGA BRCA -0.143; TCGA HNSC -0.09; TCGA KIRP -0.151; TCGA LGG -0.062; TCGA LUAD -0.094; TCGA LUSC -0.091; TCGA PAAD -0.088; TCGA PRAD -0.113
hsa-miR-708-3p
VPS13A
10 cancers: BLCA; BRCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; PAAD; SARC
mirMAP
TCGA BLCA -0.072; TCGA BRCA -0.104; TCGA CESC -0.075; TCGA COAD -0.101; TCGA ESCA -0.166; TCGA KIRC -0.077; TCGA KIRP -0.088; TCGA LUAD -0.054; TCGA PAAD -0.158; TCGA SARC -0.081
hsa-miR-708-3p
CHMP2B
10 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; SARC; STAD
miRNATAP
TCGA BLCA -0.078; TCGA CESC -0.087; TCGA COAD -0.072; TCGA ESCA -0.2; TCGA HNSC -0.097; TCGA KIRC -0.065; TCGA LUAD -0.077; TCGA LUSC -0.114; TCGA SARC -0.077; TCGA STAD -0.054
hsa-miR-708-3p
PAFAH2
13 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; THCA; STAD; UCEC
MirTarget
TCGA BRCA -0.088; TCGA CESC -0.103; TCGA COAD -0.084; TCGA ESCA -0.242; TCGA HNSC -0.14; TCGA KIRC -0.098; TCGA KIRP -0.054; TCGA LUAD -0.091; TCGA LUSC -0.152; TCGA PRAD -0.081; TCGA THCA -0.095; TCGA STAD -0.083; TCGA UCEC -0.063
hsa-miR-708-3p
TMF1
11 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; KIRP; LUAD; LUSC; PRAD; STAD
MirTarget
TCGA BRCA -0.051; TCGA CESC -0.177; TCGA COAD -0.084; TCGA ESCA -0.19; TCGA HNSC -0.165; TCGA KIRC -0.067; TCGA KIRP -0.125; TCGA LUAD -0.061; TCGA LUSC -0.161; TCGA PRAD -0.057; TCGA STAD -0.055
hsa-miR-708-3p
RALGPS1
9 cancers: BRCA; ESCA; KIRC; KIRP; LGG; LUAD; PAAD; SARC; STAD
mirMAP
TCGA BRCA -0.121; TCGA ESCA -0.396; TCGA KIRC -0.279; TCGA KIRP -0.191; TCGA LGG -0.111; TCGA LUAD -0.086; TCGA PAAD -0.268; TCGA SARC -0.069; TCGA STAD -0.13
hsa-miR-708-3p
RBM47
9 cancers: BRCA; CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PAAD
mirMAP
TCGA BRCA -0.095; TCGA CESC -0.143; TCGA COAD -0.165; TCGA ESCA -0.394; TCGA HNSC -0.241; TCGA KIRC -0.14; TCGA LUAD -0.072; TCGA LUSC -0.167; TCGA PAAD -0.176
hsa-miR-708-3p
TMBIM6
9 cancers: CESC; COAD; ESCA; HNSC; LUAD; LUSC; PRAD; THCA; STAD
MirTarget
TCGA CESC -0.069; TCGA COAD -0.104; TCGA ESCA -0.122; TCGA HNSC -0.088; TCGA LUAD -0.073; TCGA LUSC -0.095; TCGA PRAD -0.089; TCGA THCA -0.057; TCGA STAD -0.059
hsa-miR-708-3p
FGD4
9 cancers: CESC; COAD; ESCA; HNSC; KIRC; LUAD; LUSC; PRAD; STAD
MirTarget
TCGA CESC -0.155; TCGA COAD -0.124; TCGA ESCA -0.317; TCGA HNSC -0.153; TCGA KIRC -0.078; TCGA LUAD -0.213; TCGA LUSC -0.342; TCGA PRAD -0.242; TCGA STAD -0.093
hsa-miR-708-3p
BEND7
9 cancers: CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; STAD
mirMAP
TCGA CESC -0.524; TCGA ESCA -0.593; TCGA HNSC -0.21; TCGA KIRP -0.078; TCGA LGG -0.091; TCGA LUAD -0.171; TCGA LUSC -0.4; TCGA PAAD -0.211; TCGA STAD -0.156
hsa-miR-708-3p
ACOX1
9 cancers: COAD; ESCA; HNSC; KIRC; LUAD; PAAD; PRAD; THCA; STAD
mirMAP
TCGA COAD -0.096; TCGA ESCA -0.199; TCGA HNSC -0.125; TCGA KIRC -0.065; TCGA LUAD -0.111; TCGA PAAD -0.161; TCGA PRAD -0.081; TCGA THCA -0.065; TCGA STAD -0.122





Enriched cancer pathways of putative targets